These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7010571)

  • 1. Mechanisms of stone formation: role of promoters and inhibitors.
    Fleisch H
    Scand J Urol Nephrol Suppl; 1980; 53():53-66. PubMed ID: 7010571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors and promoters of stone formation.
    Fleisch H
    Kidney Int; 1978 May; 13(5):361-71. PubMed ID: 351264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macromolecular inhibitors of calcium oxalate crystal growth and aggregation.
    Brockis JG; Bowyer RC; McCulloch RK
    Scand J Urol Nephrol Suppl; 1980; 53():67-74. PubMed ID: 6938008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of calcium oxalate crystallization and urolithiasis.
    Grases F; Conte A; Genestar C; Costa-Bauzá A
    Urol Int; 1992; 48(4):409-14. PubMed ID: 1413303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors.
    Meyer JL; Smith LH
    Invest Urol; 1975 Jul; 13(1):36-9. PubMed ID: 166960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical chemical studies of calcium oxalate crystallization.
    Nancollas GH; Smesko SA; Campbell AA; Richardson CF; Johnsson M; Iadiccico RA; Binette JP; Binette M
    Am J Kidney Dis; 1991 Apr; 17(4):392-5. PubMed ID: 2008905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic calcium oxalate urolithiasis and endogenous oxalate production.
    Baker PW; Rofe AM; Bais R
    Crit Rev Clin Lab Sci; 1996; 33(1):39-82. PubMed ID: 8833627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones.
    Sallis JD; Lumley MF
    Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium salt urolithiasis. Review of theory for diagnosis and management.
    Györy AZ; Ashby R
    Clin Nephrol; 1999 Apr; 51(4):197-208. PubMed ID: 10230552
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of spherulites of calcium phosphate and crystallization of calcium oxalate in gel in a new experimental model of urinary stone formation.
    Achilles W; Jöckel U; Schaper A; Burk M; Ulshöfer B; Riedmiller H
    Investig Urol (Berl); 1994; 5():218-21. PubMed ID: 7719309
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation.
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Invest Urol; 1981 Mar; 18(5):382-6. PubMed ID: 6162821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation between calcium phosphates and calcium oxalates in urinary calculi].
    Heughebaert JC
    Nephrologie; 1984; 5(4):163-70. PubMed ID: 6098838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoters and inhibitors of calcium urolithiasis in children.
    Lama G; Carbone MG; Marrone N; Russo P; Spagnuolo G
    Child Nephrol Urol; 1990; 10(2):81-4. PubMed ID: 2253256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model system for the investigation of urinary stone formation.
    Bouropoulos N; Bouropoulos C; Klepetsanis PG; Melekos M; Barbalias G; Koutsoukos PG
    Br J Urol; 1996 Aug; 78(2):169-75. PubMed ID: 8813906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth of calcium oxalate crystals. I. A model for urinary stone growth.
    Meyer JL; Smith LH
    Invest Urol; 1975 Jul; 13(1):31-5. PubMed ID: 1140917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of urinary material and glycosaminoglycans on calcium oxalate monohydrate crystal aggregation].
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1000-3. PubMed ID: 2514310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.